免疫タンパク質診断検査市場規模、シェア、動向分析レポート：検査別、技術別、最終用途別、流通チャネル別、地域別、セグメント別予測、2025年～2030年

免疫タンパク質診断検査市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の免疫タンパク質診断検査市場規模は、2025～2030年にかけて7.7%のCAGRを記録し、2030年には148億6,000万米ドルに達する見込みです。

この成長は慢性疾患の罹患率の上昇に起因しています。

米国心臓協会の2017年の統計によると、米国では毎年79万人近くが心臓発作を経験しており、さらに脳卒中は米国での死亡者20人に1人の原因となっています。前述の要因の結果として、迅速な診断を促進するために、免疫タンパク質診断の需要は増加すると予想されます。

WHOによると、2015年には世界中で肺がんによる死亡が169万人近く登録されています。したがって、このような慢性疾患の迅速かつ正確な診断は、高い死亡率を減らすために重要になっています。免疫タンパク質診断装置と試薬は、慢性疾患を迅速に検出する上で非常に有効であることが証明されています。

免疫タンパク質診断セグメントにおける技術の進歩は、新しい製品の採用つながっています。例えば、DiaSorin製のLIAISON XLは、全自動化学発光分析装置であり、完全なサンプル処理を容易にします。また、検査サンプルの測定と評価を行うことにより、システムの効率とスループットを向上させています。

免疫タンパク質診断検査市場レポートハイライト

• 免疫グロブリン診断検査セグメントは、2024年に27.1%の市場最大収益シェアを占めました。これらの検査は、免疫不全、自己免疫疾患、感染症を含む幅広い疾患の診断に重要な役割を果たすため、免疫タンパク質診断検査市場を独占しています。
• 感染症検査セグメントは、2024年に24.2％の市場最大の売上シェアを占めました。感染症検査は、感染症の有病率の増加、早期かつ正確な診断の必要性、公衆衛生管理においてこれらの検査が果たす重要な役割により、高い需要があります。
• 2024年には、酵素ベースのイムノアッセイセグメンテーションが25.0％と、市場で最大の収益シェアを占めました。
• 小売販売部門は、2024年に54.1%の最大シェアを占めました。この成長は、患者にとってのアクセス性と利便性の向上に起因しています。
• 病院・クリニックセグメントは、2024年に44.7%と、市場で最大の売上シェアを占めました。病院やクリニックでは、毎日多数の患者が受診するため、診断検査サービスに対する需要が高まっている
• 北米の免疫タンパク質診断検査産業が優勢で、2024年には45.32%のシェアを占めました。市場の優位性は、技術の進歩、慢性疾患の高い有病率、研究開発への投資の拡大に起因します。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 免疫タンパク質診断検査市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/付随市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 免疫タンパク質診断検査市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 免疫タンパク質診断検査市場：検査別、推定・動向分析

• 検査市場シェア、2024年と2030年
• セグメントダッシュボード
• 検査による世界の免疫タンパク質診断検査市場展望
• 2018～2030年の市場規模と予測と動向分析
  • 補体系タンパク質診断検査
  • 無料の軽鎖診断テスト
  • ハプトグロビン診断検査
  • 免疫グロブリン診断検査
  • プレアルブミン診断検査
  • C反応性タンパク質（CRP）診断検査

第5章 免疫タンパク質診断検査市場：用途別、推定・動向分析

• 用途市場シェア、2024年と2030年
• セグメントダッシュボード
• 用途による世界の免疫タンパク質診断検査市場展望
• 2018～2030年の市場規模と予測と動向分析
  • 感染症検査
  • 腫瘍学検査
  • 内分泌検査
  • 毒性検査
  • アレルギー検査
  • 自己免疫疾患検査

第6章 免疫タンパク質診断検査市場：技術別、推定・動向分析

• 技術市場シェア、2024年と2030年
• セグメントダッシュボード
• 技術による世界の免疫タンパク質診断検査市場の展望
• 2018～2030年の市場規模と予測と動向分析
  • 放射免疫測定
  • 酵素免疫測定法
  • 化学発光アッセイ
  • 免疫蛍光アッセイ
  • 免疫濁度アッセイ
  • 免疫タンパク質電気泳動

第7章 免疫タンパク質診断検査市場：最終用途別、推定・動向分析

• 最終用途市場シェア、2024年と2030年
• セグメントダッシュボード
• 最終用途による世界の免疫タンパク質診断検査市場の展望
• 2018～2030年の市場規模と予測と動向分析
  • 病院とクリニック
  • 診断ラボ
  • その他

第8章 免疫タンパク質診断検査市場：流通チャネル別、推定・動向分析

• 流通チャネル市場シェア、2024年と2030年
• セグメントダッシュボード
• 流通チャネルによる世界の免疫タンパク質診断検査市場の展望
• 2018～2030年の市場規模と予測と動向分析
  • 直接入札
  • 小売販売

第9章 免疫タンパク質診断検査市場：地域別、推定・動向分析

• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 世界地域市場のスナップショット
• 市場規模と予測動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 主要企業の市場シェア分析、2024年
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • Thermo Fisher Scientific Inc
  • PerkinElmer Inc
  • Bio-Rad Laboratories, Inc
  • Aurora Biomed Inc.
  • Tecan Trading AG
  • Promega Corporation
  • Charles River Laboratories
  • Creative Biolabs

List of Tables

• Table. 1 List of Abbreviation
• Table. 2 North America immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 3 North America immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 4 North America immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 5 North America immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 6 North America immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 7 U.S. immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 8 U.S. immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 9 U.S. immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 10 U.S. immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 11 U.S. immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 12 Canada immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 13 Canada immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 14 Canada immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 15 Canada immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 16 Canada immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 17 Mexico immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 18 Mexico immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 19 Mexico immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 20 Mexico immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 21 Mexico immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 22 Europe immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 23 Europe immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 24 Europe immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 25 Europe immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 26 Europe immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 27 UK immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 28 UK immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 29 UK immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 30 UK immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 31 UK immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 32 Germany immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 33 Germany immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 34 Germany immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 35 Germany immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 36 Germany immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 37 France immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 38 France immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 39 France immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 40 France immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 41 France immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 42 Italy immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 43 Italy immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 44 Italy immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 45 Italy immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 46 Italy immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 47 Spain immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 48 Spain immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 49 Spain immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 50 Spain immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 51 Spain immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 52 Denmark immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 53 Denmark immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 54 Denmark immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 55 Denmark immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 56 Denmark immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 57 Sweden immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 58 Sweden immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 59 Sweden immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 60 Sweden immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 61 Sweden immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 62 Norway immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 63 Norway immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 64 Norway immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 65 Norway immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 66 Norway immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 67 Asia Pacific immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 68 Asia Pacific immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 69 Asia Pacific immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 70 Asia Pacific immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 71 Asia Pacific immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 72 Japan immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 73 Japan immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 74 Japan immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 75 Japan immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 76 Japan immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 77 China immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 78 China immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 79 China immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 80 China immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 81 China immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 82 India immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 83 India immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 84 India immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 85 India immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 86 India immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 87 Australia immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 88 Australia immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 89 Australia immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 90 Australia immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 91 Australia immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 92 Thailand immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 93 Thailand immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 94 Thailand immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 95 Thailand immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 96 Thailand immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 97 South Korea immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 98 South Korea immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 99 South Korea immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 100 South Korea immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 101 South Korea immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 102 Latin America immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 103 Latin America immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 104 Latin America immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 105 Latin America immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 106 Latin America immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 107 Brazil immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 108 Brazil immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 109 Brazil immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 110 Brazil immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 111 Brazil immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 112 Argentina immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 113 Argentina immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 114 Argentina immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 115 Argentina immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 116 Argentina immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 117 Middle East & Africa immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 118 Middle East & Africa immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 119 Middle East & Africa immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 120 Middle East & Africa immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 121 Middle East & Africa immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 122 South Africa immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 123 South Africa immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 124 South Africa immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 125 South Africa immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 126 South Africa immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 127 Saudi Arabia immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 128 Saudi Arabia immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 129 Saudi Arabia immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 130 Saudi Arabia immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 131 Saudi Arabia immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 132 UAE immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 133 UAE immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 134 UAE immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 135 UAE immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 136 UAE immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)
• Table. 137 Kuwait immunoprotein diagnostic testing market, by test, 2018 - 2030 (USD Million)
• Table. 138 Kuwait immunoprotein diagnostic testing market, by application, 2018 - 2030 (USD Million)
• Table. 139 Kuwait immunoprotein diagnostic testing market, by technology, 2018 - 2030 (USD Million)
• Table. 140 Kuwait immunoprotein diagnostic testing market, by end use, 2018 - 2030 (USD Million)
• Table. 141 Kuwait immunoprotein diagnostic testing market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Immunoprotein Diagnostic Testing: Market outlook
• Fig. 9 Immunoprotein Diagnostic Testing: Competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 Industry value chain analysis
• Fig. 14 Immunoprotein Diagnostic Testing Market driver impact
• Fig. 15 Immunoprotein Diagnostic Testing Market restraint impact
• Fig. 16 Immunoprotein Diagnostic Testing Market strategic initiatives analysis
• Fig. 17 Immunoprotein Diagnostic Testing market: Test movement analysis
• Fig. 18 Immunoprotein Diagnostic Testing market: Test outlook and key takeaways
• Fig. 19 Complement System Proteins Diagnostic Tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Free Light Chain Diagnostic Tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Haptoglobin Diagnostic Test market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Immunoglobulin Diagnostic Tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Prealbumin Diagnostic Tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 C-Reactive Protein (CRP) Diagnostic Tests market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Immunoprotein Diagnostic Testing market: Application movement analysis
• Fig. 26 Immunoprotein Diagnostic Testing market: Application outlook and key takeaways
• Fig. 27 Infectious Disease Testing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Oncology Testing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Endocrine Testing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Toxicology Testing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Allergy Testing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Autoimmune Disease Testing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Immunoprotein Diagnostic Testing market: Technology movement analysis
• Fig. 34 Immunoprotein Diagnostic Testing market: Technology outlook and key takeaways
• Fig. 35 Radioimmunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Enzyme Based Immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Chemiluminescence Assay market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Immunofluorescence Assay market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Immunoturbidity Assay market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Immunoprotein Electrophoresis market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Immunoprotein Diagnostic Testing market: End Use movement analysis
• Fig. 42 Immunoprotein Diagnostic Testing market: End Use outlook and key takeaways
• Fig. 43 Hospitals and Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Diagnostic Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Immunoprotein Diagnostic Testing market: Distribution Channel movement analysis
• Fig. 47 Immunoprotein Diagnostic Testing market: Distribution Channel outlook and key takeaways
• Fig. 48 Direct Tender market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Retail Sales market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 U.K. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Immunoprotein Diagnostic Testing Market Growth & Trends:

The global Immunoprotein Diagnostic testing market size is expected to reach USD 14.86 billion by 2030, registering a CAGR of 7.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth can be attributed to the rising incidence of chronic diseases.

According to American Heart Association's 2017 statistics, nearly 790,000 people experience heart attack every year in the U.S. In addition, stroke is responsible for 1 in every 20 deaths in the U.S. Hence, WHO is also taking initiatives to reduce the risk of cardiovascular diseases. As a result of the aforementioned factors, the demand for Immunoprotein Diagnostic is expected to rise in order to facilitate rapid diagnosis.

According to WHO, nearly 1.69 million deaths due to lung cancer were registered in 2015 throughout the world. Hence, fast and accurate diagnosis of such chronic diseases has become important to reduce the high mortality rate. Immunoprotein diagnostic devices and reagents have proved to be highly effective in rapidly detecting chronic diseases.

Technological advancements in the field of Immunoprotein Diagnostic have led to introduction of novel products. For instance, LIAISON XL, manufactured by DiaSorin, is a fully automated chemiluminescence analyzer that facilitates complete sample processing. It also measures and evaluates testing samples, thereby, enhancing the efficiency and throughput of the system.

Immunoprotein Diagnostic Testing Market Report Highlights:

• The immunoglobulin diagnostic tests segment accounted for the largest revenue share of the market of 27.1% in 2024. These tests dominate the immunoprotein diagnostic testing market due to their critical role in diagnosing a wide range of conditions, including immune deficiencies, autoimmune disorders, and infectious diseases.
• The infectious disease testing segment accounted for the largest revenue share of the market of 24.2% in 2024. Infectious disease testing is in high demand due to the increasing prevalence of infectious diseases, the need for early and accurate diagnosis, and the critical role these tests play in managing public health.
• The enzyme-based immunoassay segment accounted for the largest revenue share of the market of 25.0% in 2024.
• The retail sales segment accounted for the largest share of the market of 54.1% in 2024. This growth can be attributed to the increased accessibility and convenience for patients.
• The hospitals and clinics segment accounted for the largest revenue share of the market of 44.7% in 2024. Hospitals and clinics serve a large number of patients daily, driving a high demand for diagnostic testing services.
• North America immunoprotein diagnostic testing industry dominated and accounted for a 45.32% share in 2024. The market dominance can be attributed to technological advancements, the high prevalence of chronic diseases, and growing investments in research and development.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Test
  • 1.2.2. Application
  • 1.2.3. Technology
  • 1.2.4. End Use
  • 1.2.5. Distribution Channel
  • 1.2.6. Regional scope
  • 1.2.7. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Test outlook
  • 2.2.2. Application outlook
  • 2.2.3. Technology outlook
  • 2.2.4. End Use outlook
  • 2.2.5. Distribution channel outlook
  • 2.2.6. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Immunoprotein Diagnostic Testing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising Prevalence of Chronic Diseases
    • 3.2.1.2. Technological Advancements
    • 3.2.1.3. Growing Focus on Personalized Medicine
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High Cost of Diagnostic Tests
    • 3.2.2.2. Regulatory Challenges
• 3.3. Immunoprotein Diagnostic Testing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Immunoprotein Diagnostic Testing Market: Test Estimates & Trend Analysis

• 4.1. Test Market Share, 2024 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Immunoprotein Diagnostic Testing Market by Test Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. Complement System Proteins Diagnostic Tests
    • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Free Light Chain Diagnostic Tests
    • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Haptoglobin Diagnostic Tests
    • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Immunoglobulin Diagnostic Tests
    • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.5. Prealbumin Diagnostic Tests
    • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.6. C-Reactive Protein (CRP) Diagnostic Tests
    • 4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Immunoprotein Diagnostic Testing Market: Application Estimates & Trend Analysis

• 5.1. Application Market Share, 2024 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Immunoprotein Diagnostic Testing Market by Application Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Infectious Disease Testing
    • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Oncology Testing
    • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Endocrine Testing
    • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Toxicology Testing
    • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.5. Allergy Testing
    • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.6. Autoimmune Disease Testing
    • 5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Immunoprotein Diagnostic Testing Market: Technology Estimates & Trend Analysis

• 6.1. Technology Market Share, 2024 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Immunoprotein Diagnostic Testing Market by Technology Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.4.1. Radioimmunoassay
    • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.2. Enzyme Based Immunoassay
    • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.3. Chemiluminescence Assay
    • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.4. Immunofluorescence Assay
    • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.5. Immunoturbidity Assay
    • 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4.6. Immunoprotein Electrophoresis
    • 6.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Immunoprotein Diagnostic Testing Market: End Use Estimates & Trend Analysis

• 7.1. End Use Market Share, 2024 & 2030
• 7.2. Segment Dashboard
• 7.3. Global Immunoprotein Diagnostic Testing Market by End Use Outlook
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.4.1. Hospitals and Clinics
    • 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Diagnostic Laboratories
    • 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. Others
    • 7.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Immunoprotein Diagnostic Testing Market: Distribution Channel Estimates & Trend Analysis

• 8.1. Distribution Channel Market Share, 2024 & 2030
• 8.2. Segment Dashboard
• 8.3. Global Immunoprotein Diagnostic Testing Market by Distribution Channel Outlook
• 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 8.4.1. Direct Tender
    • 8.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. Retail Sales
    • 8.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Immunoprotein Diagnostic Testing Market: Regional Estimates & Trend Analysis

• 9.1. Regional Market Share Analysis, 2024 & 2030
• 9.2. Regional Market Dashboard
• 9.3. Global Regional Market Snapshot
• 9.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 9.5. North America
  • 9.5.1. U.S.
    • 9.5.1.1. Key country dynamics
    • 9.5.1.2. Regulatory framework/ reimbursement structure
    • 9.5.1.3. Competitive scenario
    • 9.5.1.4. Target disease prevalence
    • 9.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.2. Canada
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory framework/ reimbursement structure
    • 9.5.2.3. Competitive scenario
    • 9.5.2.4. Target disease prevalence
    • 9.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.3. Mexico
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Regulatory framework/ reimbursement structure
    • 9.5.3.3. Competitive scenario
    • 9.5.3.4. Target disease prevalence
    • 9.5.3.5. Mexico market estimates and forecasts 2018 to 2030, (USD Million
• 9.6. Europe
  • 9.6.1. UK
    • 9.6.1.1. Key country dynamics
    • 9.6.1.2. Regulatory framework/ reimbursement structure
    • 9.6.1.3. Competitive scenario
    • 9.6.1.4. Target disease prevalence
    • 9.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.2. Germany
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory framework/ reimbursement structure
    • 9.6.2.3. Competitive scenario
    • 9.6.2.4. Target disease prevalence
    • 9.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.3. France
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Regulatory framework/ reimbursement structure
    • 9.6.3.3. Competitive scenario
    • 9.6.3.4. Target disease prevalence
    • 9.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.4. Italy
    • 9.6.4.1. Key country dynamics
    • 9.6.4.2. Regulatory framework/ reimbursement structure
    • 9.6.4.3. Competitive scenario
    • 9.6.4.4. Target disease prevalence
    • 9.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.5. Spain
    • 9.6.5.1. Key country dynamics
    • 9.6.5.2. Regulatory framework/ reimbursement structure
    • 9.6.5.3. Competitive scenario
    • 9.6.5.4. Target disease prevalence
    • 9.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.6. Norway
    • 9.6.6.1. Key country dynamics
    • 9.6.6.2. Regulatory framework/ reimbursement structure
    • 9.6.6.3. Competitive scenario
    • 9.6.6.4. Target disease prevalence
    • 9.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.7. Sweden
    • 9.6.7.1. Key country dynamics
    • 9.6.7.2. Regulatory framework/ reimbursement structure
    • 9.6.7.3. Competitive scenario
    • 9.6.7.4. Target disease prevalence
    • 9.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.8. Denmark
    • 9.6.8.1. Key country dynamics
    • 9.6.8.2. Regulatory framework/ reimbursement structure
    • 9.6.8.3. Competitive scenario
    • 9.6.8.4. Target disease prevalence
    • 9.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 9.7. Asia Pacific
  • 9.7.1. Japan
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Regulatory framework/ reimbursement structure
    • 9.7.1.3. Competitive scenario
    • 9.7.1.4. Target disease prevalence
    • 9.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.2. China
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Regulatory framework/ reimbursement structure
    • 9.7.2.3. Competitive scenario
    • 9.7.2.4. Target disease prevalence
    • 9.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.3. India
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Regulatory framework/ reimbursement structure
    • 9.7.3.3. Competitive scenario
    • 9.7.3.4. Target disease prevalence
    • 9.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.4. Australia
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Regulatory framework/ reimbursement structure
    • 9.7.4.3. Competitive scenario
    • 9.7.4.4. Target disease prevalence
    • 9.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.5. South Korea
    • 9.7.5.1. Key country dynamics
    • 9.7.5.2. Regulatory framework/ reimbursement structure
    • 9.7.5.3. Competitive scenario
    • 9.7.5.4. Target disease prevalence
    • 9.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.6. Thailand
    • 9.7.6.1. Key country dynamics
    • 9.7.6.2. Regulatory framework/ reimbursement structure
    • 9.7.6.3. Competitive scenario
    • 9.7.6.4. Target disease prevalence
    • 9.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 9.8. Latin America
  • 9.8.1. Brazil
    • 9.8.1.1. Key country dynamics
    • 9.8.1.2. Regulatory framework/ reimbursement structure
    • 9.8.1.3. Competitive scenario
    • 9.8.1.4. Target disease prevalence
    • 9.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8.2. Argentina
    • 9.8.2.1. Key country dynamics
    • 9.8.2.2. Regulatory framework/ reimbursement structure
    • 9.8.2.3. Competitive scenario
    • 9.8.2.4. Target disease prevalence
    • 9.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 9.9. MEA
  • 9.9.1. South Africa
    • 9.9.1.1. Key country dynamics
    • 9.9.1.2. Regulatory framework/ reimbursement structure
    • 9.9.1.3. Competitive scenario
    • 9.9.1.4. Target disease prevalence
    • 9.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.2. Saudi Arabia
    • 9.9.2.1. Key country dynamics
    • 9.9.2.2. Regulatory framework/ reimbursement structure
    • 9.9.2.3. Competitive scenario
    • 9.9.2.4. Target disease prevalence
    • 9.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.3. UAE
    • 9.9.3.1. Key country dynamics
    • 9.9.3.2. Regulatory framework/ reimbursement structure
    • 9.9.3.3. Competitive scenario
    • 9.9.3.4. Target disease prevalence
    • 9.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.4. Kuwait
    • 9.9.4.1. Key country dynamics
    • 9.9.4.2. Regulatory framework/ reimbursement structure
    • 9.9.4.3. Competitive scenario
    • 9.9.4.4. Target disease prevalence
    • 9.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Company/Competition Categorization
• 10.3. Vendor Landscape
  • 10.3.1. Key company market share analysis, 2024
  • 10.3.2. Agilent Technologies, Inc.
    • 10.3.2.1. Company overview
    • 10.3.2.2. Financial performance
    • 10.3.2.3. Product benchmarking
    • 10.3.2.4. Strategic initiatives
  • 10.3.3. Danaher Corporation
    • 10.3.3.1. Company overview
    • 10.3.3.2. Financial performance
    • 10.3.3.3. Product benchmarking
    • 10.3.3.4. Strategic initiatives
  • 10.3.4. Thermo Fisher Scientific Inc
    • 10.3.4.1. Company overview
    • 10.3.4.2. Financial performance
    • 10.3.4.3. Product benchmarking
    • 10.3.4.4. Strategic initiatives
  • 10.3.5. PerkinElmer Inc
    • 10.3.5.1. Company overview
    • 10.3.5.2. Financial performance
    • 10.3.5.3. Product benchmarking
    • 10.3.5.4. Strategic initiatives
  • 10.3.6. Bio-Rad Laboratories, Inc
    • 10.3.6.1. Company overview
    • 10.3.6.2. Financial performance
    • 10.3.6.3. Product benchmarking
    • 10.3.6.4. Strategic initiatives
  • 10.3.7. Aurora Biomed Inc.
    • 10.3.7.1. Company overview
    • 10.3.7.2. Financial performance
    • 10.3.7.3. Product benchmarking
    • 10.3.7.4. Strategic initiatives
  • 10.3.8. Tecan Trading AG
    • 10.3.8.1. Company overview
    • 10.3.8.2. Financial performance
    • 10.3.8.3. Product benchmarking
    • 10.3.8.4. Strategic initiatives
  • 10.3.9. Promega Corporation
    • 10.3.9.1. Company overview
    • 10.3.9.2. Financial performance
    • 10.3.9.3. Product benchmarking
    • 10.3.9.4. Strategic initiatives
  • 10.3.10. Charles River Laboratories
    • 10.3.10.1. Company overview
    • 10.3.10.2. Financial performance
    • 10.3.10.3. Product benchmarking
    • 10.3.10.4. Strategic initiatives
  • 10.3.11. Creative Biolabs
    • 10.3.11.1. Company overview
    • 10.3.11.2. Financial performance
    • 10.3.11.3. Product benchmarking
    • 10.3.11.4. Strategic initiatives